Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, Gesine Respondek, María Stamelou et al.|Movement Disorders|2017Cited by 2.3k
Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe ConsortiumIrina Alafuzoff, Hans Kretzschmar, Andrew King et al.|Brain Pathology|2008Cited by 479
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe ConsortiumIrina Alafuzoff, Hans A. Kretzschmar, Paul G. Ince et al.|Acta Neuropathologica|2009Cited by 329
In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damageLuigi Zecca, Georg Becker, Daniela Berg et al.|Movement Disorders|2005Cited by 212
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger et al.|Movement Disorders|2017Cited by 163